Use of atomoxetine is only recommended for those who are at least six years old. David Robertson, David Wong, a co-discoverer of fluoxetine , and Joseph Krushinski are listed as inventors on the patent application filed in 1986 and granted in 1990. Common side effects of atomoxetine include abdominal pain, loss of appetite, nausea, feeling tired, and dizziness.Atomoxetine is approved for use in children, adolescents, and adults.While its efficacy may be less than that of stimulant medications,The initial therapeutic effects of atomoxetine usually take 2–4 weeks to become apparent.Common side effects include abdominal pain, loss of appetite, nausea, feeling tired, and dizziness.Atomoxetine is relatively non-toxic in overdose. Rapidly absorbed following oral administration, with peak plasma concentration attained in approximately 1–2 hours. Duloxetine was created by Lilly researchers. 1 In patients with the poor metabolizer CYP2D6 phenotype, AUC and peak plasma … In placebo-controlled clinical trials of up to nine weeks' duration of patients with MDD, a systematic evaluation of discontinuation symptoms in patients taking duloxetine following abrupt discontinuation found the following symptoms occurring at a rate greater than or equal to 2% and at a significantly higher rate in duloxetine-treated patients compared to those discontinuing from placebo: dizziness, nausea, headache, paresthesia, vomiting, irritability, and nightmare.In the United States all antidepressants, including duloxetine carry a In 2005, the United States FDA released a public health advisory noting that there had been eleven reports of suicide attempts and three reports of suicidality within the mostly middle-aged women participating in the open label extension trials of duloxetine for the treatment of stress urinary incontinence. All people who take atomoxetine need to be watched closely. A year later Lilly abandoned the pursuit of this indication in the U.S. market.The FDA approved duloxetine for the treatment of generalized anxiety disorder in February 2007.Cymbalta generated sales of nearly $5 billion in 2012 with $4 billion of that in the U.S., but its patent protection terminated January 1, 2014.  The (+)-enantiomer of LY227942, assigned LY248686, was chosen for further studies, because it inhibited serotonin reuptake in rat synaptosomes two times more potently than (-)-enantiome… Serotonin-norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant used in the treatment of clinical depression and other affective disorders. The FDA described the potential role of confounding social stressors "unclear". In some studies, atomoxetine raised the risk of suicidal thoughts or actions in children and teens. In Australia, Portugal and Romania, atomoxetine is sold under the brand name Strattera. Like many psychiatric drugs, antidepressants were discovered by accident. includes Cymbalta This article is a stub, you can help the wiki by editing it and adding accurate information. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or … While duloxetine has demonstrated improvement in depression-related symptoms compared to Duloxetine is more effective than placebo in the treatment of Duloxetine was approved for the pain associated with diabetic The comparative efficacy of duloxetine and established pain-relief medications for DPN is unclear. Atomoxetin je lék určený k léčbě příznaků hyperkinetické poruchy, známé také jako ADHD nebo attention deficit hyperactivity disorder. Liver transaminase elevations resulted in the discontinuation of 0.3% (89/29,435) of Cymbalta-treated patients. In addition, the FDA has reported on life-threatening drug interactions that may be possible when co-administered with In a trial for major depressive disorder (MDD), the most commonly reported treatment-emergent adverse events among duloxetine-treated patients were In four clinical trials of duloxetine for the treatment of MDD, When discontinuing treatment with duloxetine, the manufacturer recommends a gradual reduction in the dose, rather than abrupt cessation, whenever possible. Používá se samotný nebo společně s léky ze skupiny stimulantů.Doporučuje se pouze dospělým a dětem od 6 let věku. In addition, one death from suicide was reported in a Cymbalta clinical pharmacology study in a healthy female volunteer without SUI. Duloxetine was approved for medical use in the United States in 2004.Duloxetine is recommended as a first-line agent for the treatment of chemotherapy-induced neuropathy by the Duloxetine was approved for the treatment of major depression in 2004.